A multimodal approach to cancer-related cachexia: from theory to practice

References

• Fearon K, Strasser F, Anker SD, et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncol. 2011;12(5):489–495.
   PubMed Web of Science ®Google Scholar
• Anker MS, Holcomb R, Muscaritoli M, et al. Orphan disease status of cancer cachexia in the USA and in the European Union: a systematic review. J Cachexia Sarcopenia Muscle. 2019;10(1):22–34.
   PubMed Web of Science ®Google Scholar
• Sadeghi M, Keshavarz-Fathi M, Baracos V, et al. Cancer cachexia: diagnosis, assessment, and treatment. Crit Rev Oncol Hematol. 2018;127:91–104.
   PubMed Web of Science ®Google Scholar
• Arthur ST, Noone JM, Van Doren BA, et al. One-year prevalence, comorbidities and cost of cachexia-related inpatient admissions in the USA. Drugs Context. 2014;3:212265.
   PubMedGoogle Scholar
• Penet MF, Bhujwalla ZM. Cancer cachexia, recent advances, and future directions. Cancer J. 2015;21(2):117–122.
   PubMed Web of Science ®Google Scholar
• Argilés JM, Busquets S, Stemmler B, et al. Cancer cachexia: understanding the molecular basis. Nat Rev Cancer. 2014;14(11):754–762.
   PubMed Web of Science ®Google Scholar
• Baracos VE, Martin L, Korc M, et al. Cancer-associated cachexia. Nat Rev Dis Primers. 2018;4:17105.
   PubMed Web of Science ®Google Scholar
• Barkhudaryan A, Scherbakov N, Springer J, et al. Cardiac muscle wasting in individuals with cancer cachexia. ESC Heart Fail. 2017;4(4):458–467.
   PubMed Web of Science ®Google Scholar
• Bozzetti F. Forcing the vicious circle: sarcopenia increases toxicity, decreases response to chemotherapy and worsens with chemotherapy. Ann Oncol. 2017;28(9):2107–2118.
   PubMed Web of Science ®Google Scholar
• Schmidt SF, Rohm M, Herzig S, et al. Cancer cachexia: more than skeletal muscle wasting. Trends Cancer. 2018;4(12):849–860.
   PubMed Web of Science ®Google Scholar
• Miyamoto Y, Hanna DL, Zhang W, et al. Molecular pathways: cachexia signaling-a targeted approach to cancer treatment. Clin Cancer Res. 2016;22(16):3999–4004.
   PubMed Web of Science ®Google Scholar
• Onesti JK, Guttridge DC. Inflammation based regulation of cancer cachexia. Biomed Res Int. 2014;2014:168407.
   PubMed Web of Science ®Google Scholar
• Zhou T, Yang K, Thapa S, et al. Differences in symptom burden among cancer patients with different stages of cachexia. J Pain Symptom Manage. 2017;53(5):919–926.
   PubMed Web of Science ®Google Scholar
• Hui D. Cancer cachexia: it takes a team to fix the complex machinery. J Oncol Pract. 2016;12(11):1172–1173.
   PubMed Web of Science ®Google Scholar
• Dunne RF, Roussel B, Culakova E, et al. Characterizing cancer cachexia in the geriatric oncology population. J Geriatr Oncol. 2019;10(3):415–419.
   PubMed Web of Science ®Google Scholar
• Stene GB, Balstad TR, Leer ASM, et al. Deterioration in muscle mass and physical function differs according to weight loss history in cancer cachexia. Cancers (Basel). 2019;11(12). DOI:10.3390/cancers11121925
   PubMed Web of Science ®Google Scholar
• Kasvis P, Vigano M, Vigano A. Health-related quality of life across cancer cachexia stages. Ann Palliat Med. 2019;8(1):33–42.
   PubMed Web of Science ®Google Scholar
• Hopkinson JB. Psychosocial impact of cancer cachexia. J Cachexia Sarcopenia Muscle. 2014;5(2):89–94.
   PubMed Web of Science ®Google Scholar
• Blum D, Stene GB, Solheim TS, et al. Validation of the consensus-definition for cancer cachexia and evaluation of a classification model–a study based on data from an international multicentre project (EPCRC-CSA). Ann Oncol. 2014;25(8):1635–1642.
   PubMed Web of Science ®Google Scholar
• Martin L, Senesse P, Gioulbasanis I, et al. Diagnostic criteria for the classification of cancer-associated weight loss. J Clin Oncol. 2015;33(1):90–99.
   PubMed Web of Science ®Google Scholar
• Vagnildhaug OM, Blum D, Wilcock A, et al. The applicability of a weight loss grading system in cancer cachexia: a longitudinal analysis. J Cachexia Sarcopenia Muscle. 2017;8(5):789–797.
   PubMed Web of Science ®Google Scholar
• Bozzetti F, Mariani L. Defining and classifying cancer cachexia: a proposal by the SCRINIO Working Group. JPEN J Parenter Enteral Nutr. 2009;33(4):361–367.
   PubMed Web of Science ®Google Scholar
• Evans WJ, Morley JE, Argilés J, et al. Cachexia: a new definition. Clin Nutr. 2008;27(6):793–799.
   PubMed Web of Science ®Google Scholar
• Muscaritoli M, Anker SD, Argilés J, et al. Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by special interest groups (SIG) “cachexia-anorexia in chronic wasting diseases” and “nutrition in geriatrics. Clin Nutr. 2010;29(2):154–159.
   PubMed Web of Science ®Google Scholar
• Wesseltoft-Rao N, Hjermstad MJ, Ikdahl T, et al. Comparing two classifications of cancer cachexia and their association with survival in patients with unresected pancreatic cancer. Nutr Cancer. 2015;67(3):472–480.
   PubMed Web of Science ®Google Scholar
• Blauwhoff-Buskermolen S, De Van Der Schueren MA, Verheul HM, et al. ‘Pre-cachexia’: a non-existing phenomenon in cancer? Ann Oncol. 2014;25(8):1668–1669.
   PubMed Web of Science ®Google Scholar
• Vanhoutte G, Van De Wiel M, Wouters K, et al. Cachexia in cancer: what is in the definition? BMJ Open Gastroenterol. 2016;3(1):e000097.
   PubMed Web of Science ®Google Scholar
• Van Der Meij BS, Schoonbeek CP, Smit EF, et al. Pre-cachexia and cachexia at diagnosis of stage III non-small-cell lung carcinoma: an exploratory study comparing two consensus-based frameworks. Br J Nutr. 2013;109(12):2231–2239.
   PubMed Web of Science ®Google Scholar
• Fearon K, Argiles JM, Baracos VE, et al. Request for regulatory guidance for cancer cachexia intervention trials. J Cachexia Sarcopenia Muscle. 2015;6(4):272–274.
   PubMed Web of Science ®Google Scholar
• Naito T. Evaluation of the true endpoint of clinical trials for cancer cachexia. Asia Pac J Oncol Nurs. 2019;6(3):227–233.
   PubMed Web of Science ®Google Scholar
• Laird BJA, Balstad TR, Solheim TS. Endpoints in clinical trials in cancer cachexia: where to start? Curr Opin Support Palliat Care. 2018;12(4):445–452.
   PubMed Web of Science ®Google Scholar
• Bonomi P, Fidler MJ, Shah P, et al. Theoretical and practical implications of treating cachexia in advanced lung cancer patients. Cancers (Basel). 2019;11(11). DOI:10.3390/cancers11111619
   PubMed Web of Science ®Google Scholar
• Temel JS, Abernethy AP, Currow DC, et al. Anamorelin in patients with non-small-cell lung cancer and cachexia (ROMANA 1 and ROMANA 2): results from two randomised, double-blind, phase 3 trials. Lancet Oncol. 2016;17(4):519–531.
   PubMed Web of Science ®Google Scholar
• Roeland EJ, Bohlke K, Baracos VE, et al. Management of Cancer Cachexia: ASCO Guideline. J Clin Oncol. 2020;38(21):2438–2453.
   PubMed Web of Science ®Google Scholar
• Strasser F, Luftner D, Possinger K, et al. Comparison of orally administered cannabis extract and delta-9-tetrahydrocannabinol in treating patients with cancer-related anorexia-cachexia syndrome: a multicenter, phase III, randomized, double-blind, placebo-controlled clinical trial from the cannabis-in-cachexia-study-group. J Clin Oncol. 2006;24(21):3394–3400.
   PubMed Web of Science ®Google Scholar
• Turcott JG, Del Rocío Guillen Núñez M, Flores-Estrada D, et al. The effect of nabilone on appetite, nutritional status, and quality of life in lung cancer patients: a randomized, double-blind clinical trial. Support Care Cancer. 2018;26(9):3029–3038.
   PubMed Web of Science ®Google Scholar
• Del Fabbro E, Dev R, Hui D, et al. Effects of melatonin on appetite and other symptoms in patients with advanced cancer and cachexia: a double-blind placebo-controlled trial. J Clin Oncol. 2013;31(10):1271–1276.
   PubMed Web of Science ®Google Scholar
• Katakami N, Uchino J, Yokoyama T, et al. Anamorelin (ONO-7643) for the treatment of patients with non-small cell lung cancer and cachexia: results from a randomized, double-blind, placebo-controlled, multicenter study of Japanese patients (ONO-7643-04). Cancer. 2018;124(3):606–616.
   PubMed Web of Science ®Google Scholar
• Jatoi A, Dakhil SR, Nguyen PL, et al. A placebo-controlled double blind trial of etanercept for the cancer anorexia/weight loss syndrome: results from N00C1 from the North Central Cancer Treatment Group. Cancer. 2007;110(6):1396–1403.
   PubMed Web of Science ®Google Scholar
• Jatoi A, Ritter HL, Dueck A, et al. A placebo-controlled, double-blind trial of infliximab for cancer-associated weight loss in elderly and/or poor performance non-small cell lung cancer patients (N01C9). Lung Cancer. 2010;68(2):234–239.
   PubMed Web of Science ®Google Scholar
• Mehrzad V, Afshar R, Akbari M. Pentoxifylline treatment in patients with cancer cachexia: a double-blind, randomized, placebo-controlled clinical trial. Adv Biomed Res. 2016;5:60.
   PubMedGoogle Scholar
• Gordon JN, Trebble TM, Ellis RD, et al. Thalidomide in the treatment of cancer cachexia: a randomised placebo controlled trial. Gut. 2005;54(4):540–545.
   PubMed Web of Science ®Google Scholar
• Lundholm K, Körner U, Gunnebo L, et al. Insulin treatment in cancer cachexia: effects on survival, metabolism, and physical functioning. Clin Cancer Res. 2007;13(9):2699–2706.
   PubMed Web of Science ®Google Scholar
• Dobs AS, Boccia RV, Croot CC, et al. Effects of enobosarm on muscle wasting and physical function in patients with cancer: a double-blind, randomised controlled phase 2 trial. Lancet Oncol. 2013;14(4):335–345.
   PubMed Web of Science ®Google Scholar
• Patel AV, Friedenreich CM, Moore SC, et al. American college of sports medicine roundtable report on physical activity, sedentary behavior, and cancer prevention and control. Med Sci Sports Exerc. 2019;51(11):2391–2402.
   PubMed Web of Science ®Google Scholar
• Wennerberg E, Lhuillier C, Rybstein MD, et al. Exercise reduces immune suppression and breast cancer progression in a preclinical model. Oncotarget. 2020;11(4):452–461.
   PubMedGoogle Scholar
• Campbell KL, Winters-Stone KM, Wiskemann J, et al. Exercise Guidelines For Cancer Survivors: Consensus Statement From International Multidisciplinary Roundtable. Med Sci Sports Exerc. 2019;51(11):2375–2390.
   PubMed Web of Science ®Google Scholar
• Avancini A, Sartori G, Gkountakos A, et al. Physical activity and exercise in lung cancer care: will promises be fulfilled? Oncologist. 2020;25(3):e555–e569.
   PubMed Web of Science ®Google Scholar
• Heywood R, McCarthy AL, Skinner TL. Safety and feasibility of exercise interventions in patients with advanced cancer: a systematic review. Support Care Cancer. 2017;25(10):3031–3050.
   PubMed Web of Science ®Google Scholar
• Heywood R, McCarthy AL, Skinner TL. Efficacy of exercise interventions in patients with advanced cancer: a systematic review. Arch Phys Med Rehabil. 2018;99(12):2595–2620.
   PubMed Web of Science ®Google Scholar
• Lira FS, Neto JC, Seelaender M. Exercise training as treatment in cancer cachexia. Appl Physiol Nutr Metab. 2014;39(6):679–686.
   PubMed Web of Science ®Google Scholar
• Gould DW, Lahart I, Carmichael AR, et al. Cancer cachexia prevention via physical exercise: molecular mechanisms. J Cachexia Sarcopenia Muscle. 2013;4(2):111–124.
   PubMed Web of Science ®Google Scholar
• Grande AJ, Silva V, Riera R, et al. Exercise for cancer cachexia in adults. Cochrane Database Syst Rev. 2014;11:CD010804.
   Google Scholar
• Meneses-Echávez JF, Correa-Bautista JE, González-Jiménez E, et al. The Sis. Cancer Epidemiol Biomarkers Prev. 2016;25(7):1009–1017.
   PubMed Web of Science ®Google Scholar
• Schmidt ME, Meynköhn A, Habermann N, et al. Resistance exercise and inflammation in breast cancer patients undergoing adjuvant radiation therapy: mediation analysis from a randomized, controlled intervention trial. Int J Radiat Oncol Biol Phys. 2016;94(2):329–337.
   PubMed Web of Science ®Google Scholar
• Balstad TR, Solheim TS, Strasser F, et al. Dietary treatment of weight loss in patients with advanced cancer and cachexia: a systematic literature review. Crit Rev Oncol Hematol. 2014;91(2):210–221.
   PubMed Web of Science ®Google Scholar
• Nasrah R, Kanbalian M, Van Der Borch C, et al. Defining the role of dietary intake in determining weight change in patients with cancer cachexia. Clin Nutr. 2018;37(1):235–241.
   PubMed Web of Science ®Google Scholar
• Arends J, Baracos V, Bertz H, et al. ESPEN expert group recommendations for action against cancer-related malnutrition. Clin Nutr. 2017;36(5):1187–1196.
   PubMed Web of Science ®Google Scholar
• Bauer DJ, Ash S, Davidson W, et al. Evidence based practice guidelines for the nutritional management of cancer cachexia. Nutr Diet. 2006;63:S3–S32.
   Google Scholar
• Arends J, Bachmann P, Baracos V, et al. ESPEN guidelines on nutrition in cancer patients. Clin Nutr. 2017;36(1):11–48.
   PubMed Web of Science ®Google Scholar
• Fitschen PJ, Wilson GJ, Wilson JM, et al. Efficacy of β-hydroxy-β-methylbutyrate supplementation in elderly and clinical populations. Nutrition. 2013;29(1):29–36.
   PubMed Web of Science ®Google Scholar
• Kraft M, Kraft K, Gärtner S, et al. L-Carnitine-supplementation in advanced pancreatic cancer (CARPAN)–a randomized multicentre trial. Nutr J. 2012;11:52.
   PubMed Web of Science ®Google Scholar
• Trestini I, Carbognin L, Sperduti I, et al. Prognostic impact of early nutritional support in patients affected by locally advanced and metastatic pancreatic ductal adenocarcinoma undergoing chemotherapy. Eur J Clin Nutr. 2018;72(5):772–779.
   PubMed Web of Science ®Google Scholar
• Hopkinson JB. Food connections: a qualitative exploratory study of weight- and eating-related distress in families affected by advanced cancer. Eur J Oncol Nurs. 2016;20:87–96.
   PubMed Web of Science ®Google Scholar
• Amano K, Maeda I, Morita T, et al. Eating-related distress and need for nutritional support of families of advanced cancer patients: a nationwide survey of bereaved family members. J Cachexia Sarcopenia Muscle. 2016;7(5):527–534.
   PubMed Web of Science ®Google Scholar
• Hopkinson JB, Richardson A. A mixed-methods qualitative research study to develop a complex intervention for weight loss and anorexia in advanced cancer: the family approach to weight and eating. Palliat Med. 2015;29(2):164–176.
   PubMed Web of Science ®Google Scholar
• Hopkinson JB, Fenlon DR, Okamoto I, et al. The deliverability, acceptability, and perceived effect of the Macmillan approach to weight loss and eating difficulties: a phase II, cluster-randomized, exploratory trial of a psychosocial intervention for weight- and eating-related distress in people with advanced cancer. J Pain Symptom Manage. 2010;40(5):684–695.
   PubMed Web of Science ®Google Scholar
• Hopkinson J. Psychosocial support in cancer cachexia syndrome: the evidence for supported self-management of eating problems during radiotherapy or chemotherapy treatment. Asia Pac J Oncol Nurs. 2018;5(4):358–368.
   PubMed Web of Science ®Google Scholar
• Shragge JE, Wismer WV, Olson KL, et al. Shifting to conscious control: psychosocial and dietary management of anorexia by patients with advanced cancer. Palliat Med. 2007;21(3):227–233.
   PubMed Web of Science ®Google Scholar
• Rodin G, Lo C, Rydall A, et al. Managing cancer and living meaningfully (CALM): a randomized controlled trial of a psychological intervention for patients with advanced cancer. J Clin Oncol. 2018;36(23):2422–2432.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Pessin H, Rosenfeld B, et al. Individual meaning-centered psychotherapy for the treatment of psychological and existential distress: a randomized controlled trial in patients with advanced cancer. Cancer. 2018;124(15):3231–3239.
   PubMed Web of Science ®Google Scholar
• Buonaccorso L, Bertocchi E, Autelitano C, et al. Psychoeducational and rehabilitative intervention to manage cancer cachexia (PRICC) for patients and their caregivers: protocol for a single-arm feasibility trial. BMJ Open. 2021;11(3):e042883.
   PubMed Web of Science ®Google Scholar
• Fearon KC. Cancer cachexia: developing multimodal therapy for a multidimensional problem. Eur J Cancer. 2008;44(8):1124–1132.
   PubMed Web of Science ®Google Scholar
• Madeddu C, Maccio A, Mantovani G. Multitargeted treatment of cancer cachexia. Crit Rev Oncog. 2012;17(3):305–314.
   PubMedGoogle Scholar
• Martone AM, Marzetti E, Calvani R, et al. Exercise and protein intake: a synergistic approach against sarcopenia. Biomed Res Int. 2017;2017:2672435.
   PubMed Web of Science ®Google Scholar
• Parmar MP, Vanderbyl BL, Kanbalian M, et al. A multidisciplinary rehabilitation programme for cancer cachexia improves quality of life. BMJ Support Palliat Care. 2017;7(4):441–449.
   PubMed Web of Science ®Google Scholar
• Naito T, Mitsunaga S, Miura S, et al. Feasibility of early multimodal interventions for elderly patients with advanced pancreatic and non-small-cell lung cancer. J Cachexia Sarcopenia Muscle. 2019;10(1):73–83.
   PubMed Web of Science ®Google Scholar
• Solheim TS, Laird BJA, Balstad TR, et al. A randomized phase II feasibility trial of a multimodal intervention for the management of cachexia in lung and pancreatic cancer. J Cachexia Sarcopenia Muscle. 2017;8(5):778–788.
   PubMed Web of Science ®Google Scholar
• Breitbart W, Rosenfeld B, Pessin H, et al. Meaning-centered group psychotherapy: an effective intervention for improving psychological well-being in patients with advanced cancer. J Clin Oncol. 2015;33(7):749–754.
   PubMed Web of Science ®Google Scholar
• Wasley D, Gale N, Roberts S, et al. Patients with established cancer cachexia lack the motivation and self-efficacy to undertake regular structured exercise. Psychooncology. 2018;27(2):458–464.
   PubMed Web of Science ®Google Scholar
• Avancini A, Trestini I, Tregnago D, et al. Multidisciplinary lifestyle intervention to manage pancreatic cancer-related cachexia: a case report. Future Sci OA. 2020;7(2):FSO659.
   PubMed Web of Science ®Google Scholar